Continued Benefit Observed With Relugolix Combination Therapy in Uterine Fibroids Trial
The double-blind, placebo-controlled phase 3 study included 229 women who completed the LIBERTY long-term extension study.
Diana Ernst, RPh
Editorial Director
Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.
